Results 111 to 120 of about 22,513 (170)

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease

open access: yesKidney International Reports
Introduction: Anti–glomerular basement membrane (GBM) disease is caused by pathogenic antibodies usually targeting the noncollagenous domain of the α3 chain of type IV collagen and frequently presents as rapidly progressive glomerulonephritis and diffuse
Vanja Ivković   +15 more
doaj   +1 more source

A patient with COVID-19 and anti-glomerular basement membrane disease

open access: yesNefrología (English Edition), 2021
Neriman Sila Koc   +4 more
doaj   +3 more sources

Clinicopathological Characteristics of Anti-Glomerular Basement Membrane Disease with Atypical Features

open access: yesTurkish Journal of Nephrology, 2023
Betul Öğüt   +7 more
doaj   +1 more source

Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease. [PDF]

open access: yesJ Am Soc Nephrol, 2023
Floyd L   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy